Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Read Article
News
2024
2023
Archive
Search news articles
June 27, 2017
VIVEVE SELECTED FOR INCLUSION IN RUSSELL 2000(R) INDEX
June 20, 2017
SPYRYX BIOSCIENCES EXPANDS DEVELOPMENT AWARD WITH CYSTIC FIBROSIS FOUNDATION; PRESENTS PHASE 1 DATA FOR SPX-101 AT THE EUROPEAN CYSTIC FIBROSIS CONFERENCE
June 12, 2017
NEEDLE-FREE INJECTION – PORTAL PRIME: A DIGITALLY CONTROLLED, CLOUD-INTEGRATED JET INJECTION SYSTEM
June 7, 2017
BIRD ROCK BIO COMPLETES SINGLE ASCENDING DOSE HUMAN CLINICAL TRIAL FOR NAMACIZUMAB; GENERATES SAFETY, TOLERABILITY, AND PHARMACOKINETICS DATA; PREPARES TO INITIATE STUDY IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
May 24, 2017
PIERRE FABRE BUYS UP IGENICA PRECLINICAL I-O MEDS
May 24, 2017
APREA THERAPEUTICS ANNOUNCES FIRST PATIENTS ENROLLED IN PHASE IB/II CLINICAL STUDY OF APR-246 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME
May 16, 2017
SCIENTIST.COM RAISED $24 MILLION IN EQUITY FINANCING CO-LED BY LEERINK TRANSFORMATION PARTNERS AND 5AM VENTURES.
May 12, 2017
THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE PUBLISHES STUDY OF SPYRYX BIOSCIENCES’ SPX-101, A NOVEL ENAC-TARGETED THERAPEUTIC FOR CYSTIC FIBROSIS THAT RESTORES MUCUS TRANSPORT
April 25, 2017
PHASERX RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION FOR PRX-OTC FROM EUROPEAN MEDICINES AGENCY
April 20, 2017
AUDENTES THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
« Previous Page
1
…
3
4
5
6
7
8
Next Page »